Sagamihara, Japan

Ayako Kawabata



Average Co-Inventor Count = 8.7

ph-index = 1

Forward Citations = 27(Granted Patents)


Location History:

  • Tokyo, JP (2005)
  • Sagamihara, JP (2004 - 2007)

Company Filing History:


Years Active: 2004-2007

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ayako Kawabata: Innovator in Phospholipase Research

Introduction

Ayako Kawabata is a notable inventor based in Sagamihara, Japan. She has made significant contributions to the field of biochemistry, particularly in the study of phospholipases and their applications in medicine. With a total of three patents to her name, her work has the potential to impact various therapeutic areas.

Latest Patents

Kawabata's latest patents include a novel phospholipase Apolypeptide, which encompasses DNA encoding the polypeptide, a vector comprising the DNA, and a transformant transformed with the vector. This invention also details a method for utilizing the polypeptide, including screening for compounds with agonist or antagonist activity. Additionally, she has developed a polypeptide that inhibits the phospholipase A activity of the Apolypeptide, along with the corresponding DNA and pharmaceutical applications. Another significant patent relates to a novel DNA whose expression level fluctuates in leukocytes of IgA nephropathy patients, providing methods for diagnosis and treatment of this condition.

Career Highlights

Throughout her career, Ayako Kawabata has worked with esteemed institutions such as Nihon University and Kyowa Hakko Kogyo Co., Ltd. Her research has been pivotal in advancing our understanding of phospholipases and their role in various diseases.

Collaborations

Kawabata has collaborated with notable colleagues, including Tetsuyoshi Ishiwata and Mikiko Sakurada, contributing to a rich exchange of ideas and innovations in her field.

Conclusion

Ayako Kawabata's work exemplifies the intersection of innovation and practical application in biochemistry. Her patents not only advance scientific knowledge but also hold promise for future medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…